NASDAQ:SDGR Schrodinger (SDGR) Stock Price, News & Analysis $30.31 -0.15 (-0.49%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$30.38 +0.08 (+0.25%) As of 10/2/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Schrodinger Stock (NASDAQ:SDGR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Schrodinger alerts:Sign Up Key Stats Today's Range$29.28▼$31.1450-Day Range$15.12▼$31.0552-Week Range$10.94▼$32.45Volume3.05 million shsAverage Volume2.58 million shsMarket Capitalization$2.24 billionP/E RatioN/ADividend YieldN/APrice Target$20.80Consensus RatingHold Company Overview Schrödinger, Inc. is a technology company that develops computational software for pharmaceutical and materials research. Its platform uses physics-based modeling, machine learning and other computational methods to help scientists design and optimize molecules, evaluate potential drug candidates and investigate material properties. The company’s software offerings include molecular modeling, simulation, predictive modeling and collaborative research tools, such as Maestro, Desmond, Jaguar, FEP+ and LiveDesign. Schrödinger licenses its software to pharmaceutical, biotechnology, chemical and academic organizations worldwide, while also applying the platform to its own internal drug discovery programs and strategic collaborations. Founded in 1990, Schrödinger is named after physicist Erwin Schrödinger and is headquartered in New York City. The company is led by President and Chief Executive Officer Ramy Farid, who has overseen its development as both a scientific software provider and a biopharmaceutical research company.AI Generated. May Contain Errors. Read More Schrodinger Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks28th Percentile Overall ScoreSDGR MarketRank™: Schrodinger scored higher than 28% of companies evaluated by MarketBeat, and ranked 755th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.6 / 5Analyst RatingHold Consensus RatingSchrodinger has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 3 buy ratings, 2 hold ratings, and 1 sell rating.Downside RiskSchrodinger has a consensus price target of $20.80, representing about 31.4% downside from its current price of $30.31.Amount of Analyst CoverageSchrodinger has only been the subject of 2 research reports in the past 90 days.Read more about Schrodinger's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Schrodinger are expected to grow in the coming year, from ($1.50) to ($1.10) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Schrodinger is -40.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Schrodinger is -40.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSchrodinger has a P/B Ratio of 6.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Schrodinger's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.83% of the float of Schrodinger has been sold short.Short Interest Ratio / Days to CoverSchrodinger has a short interest ratio ("days to cover") of 8.74.Change versus previous monthShort interest in Schrodinger has recently increased by 0.72%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSchrodinger does not currently pay a dividend.Dividend GrowthSchrodinger does not have a long track record of dividend growth. News and Social Media4.4 / 5News Sentiment1.05 News SentimentSchrodinger has a news sentiment score of 1.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Schrodinger this week, compared to 3 articles on an average week.Search Interest8 people have searched for SDGR on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat Follows9 people have added Schrodinger to their MarketBeat watchlist in the last 30 days. Company Ownership1.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Schrodinger insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $928,063.00 in company stock.Percentage Held by Insiders10.10% of the stock of Schrodinger is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions79.05% of the stock of Schrodinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Schrodinger's insider trading history. Receive SDGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Schrodinger and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SDGR Stock News HeadlinesSchrodinger (NASDAQ:SDGR) Reaches New 52-Week High - What's Next?October 2 at 7:21 AM | americanbankingnews.comSchrödinger (SDGR) Could Be 29% Below Fair Value Despite A 38% Overvalued ViewSeptember 27, 2026 | finance.yahoo.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow. | Base Camp Trading (Ad)Schrodinger Stock Has Technical Strength as It Hits New 2-Year HighsSeptember 23, 2026 | finance.yahoo.comKaren Akinsanya Sells 31,599 Shares of Schrodinger (NASDAQ:SDGR) StockSeptember 23, 2026 | americanbankingnews.comSchrodinger (NASDAQ:SDGR) Insider Karen Akinsanya Sells 31,599 SharesSeptember 22, 2026 | insidertrades.comWhy DataMEDS’ acquisition does not seem to be very bullish for MEDS stock at this pointSeptember 18, 2026 | msn.comSchrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)September 18, 2026 | marketscreener.comMSee More Headlines SDGR Stock Analysis - Frequently Asked Questions How have SDGR shares performed this year? Schrodinger's stock was trading at $17.88 on January 1st, 2026. Since then, SDGR stock has increased by 69.5% and is now trading at $30.31. How were Schrodinger's earnings last quarter? Schrodinger, Inc. (NASDAQ:SDGR) issued its quarterly earnings data on Wednesday, August, 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.41) by $0.49. Schrodinger's revenue was up 7.5% on a year-over-year basis. Read the conference call transcript. When did Schrodinger IPO? Schrodinger (SDGR) raised $178 million in an IPO on Thursday, February 6th 2020. The company issued 11,882,352 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets acted as the underwriters for the IPO. How do I buy shares of Schrodinger? Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Schrodinger own? Based on aggregate information from My MarketBeat watchlists, some other companies that Schrodinger investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings8/05/2026Today10/02/2026Next Earnings (Estimated)11/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 SDGR's financial health is in the Green zone, according to TradeSmith. SDGR has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:SDGR CIK1490978 Webwww.schrodinger.com Phone212-295-5800FaxN/AEmployees850Year Founded1990Price Target and Rating Average Price Target for Schrodinger$20.80 High Price Target$24.00 Low Price Target$17.00 Potential Upside/Downside-31.4%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($0.74) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$103.26 million Net Margins-20.98% Pretax Margin-20.05% Return on Equity-16.37% Return on Assets-8.19% Debt Debt-to-Equity RatioN/A Current Ratio2.71 Quick Ratio2.71 Sales & Book Value Annual Sales$255.87 million Price / Sales8.74 Cash FlowN/A Price / Cash FlowN/A Book Value$4.94 per share Price / Book6.14Miscellaneous Outstanding Shares73,820,000Free Float66,369,000Market Cap$2.24 billion OptionableOptionable Beta1.62 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:SDGR) was last updated on 10/3/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Schrodinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Schrodinger With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
